M. Goldman

684 total citations
24 papers, 440 citations indexed

About

M. Goldman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, M. Goldman has authored 24 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in M. Goldman's work include Asthma and respiratory diseases (8 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Fungal Infections and Studies (5 papers). M. Goldman is often cited by papers focused on Asthma and respiratory diseases (8 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Fungal Infections and Studies (5 papers). M. Goldman collaborates with scholars based in United States, Singapore and United Kingdom. M. Goldman's co-authors include Matthew Graham, Jin Lin, Aileen McCabe, Marc Gurwith, John R. Wingard, Raleigh A. Bowden, Gary A. Noskin, J.-A. van Burik, Mary H. White and Carole B. Miller and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Allergy and Clinical Immunology and Respiratory Medicine.

In The Last Decade

M. Goldman

24 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Goldman United States 8 284 271 107 72 63 24 440
Stanislas Nimubona France 8 394 1.4× 345 1.3× 66 0.6× 43 0.6× 25 0.4× 12 505
D Mattson United States 5 219 0.8× 241 0.9× 38 0.4× 66 0.9× 20 0.3× 7 373
AO Soubani United States 5 243 0.9× 199 0.7× 138 1.3× 16 0.2× 22 0.3× 5 347
T. Schmeiser Germany 8 86 0.3× 126 0.5× 68 0.6× 127 1.8× 23 0.4× 12 323
Naoki Hosogaya Japan 10 164 0.6× 152 0.6× 41 0.4× 24 0.3× 13 0.2× 49 301
Fumiyuki Kuze Japan 11 181 0.6× 249 0.9× 129 1.2× 16 0.2× 36 0.6× 33 432
Inge Muylle Belgium 10 174 0.6× 135 0.5× 47 0.4× 39 0.5× 20 0.3× 12 278
J Muszyński Poland 8 155 0.5× 58 0.2× 27 0.3× 47 0.7× 28 0.4× 35 351
Joseph J. Nania United States 6 351 1.2× 320 1.2× 60 0.6× 86 1.2× 3 0.0× 6 410
Hideki Ikeda Japan 9 81 0.3× 86 0.3× 45 0.4× 20 0.3× 15 0.2× 33 247

Countries citing papers authored by M. Goldman

Since Specialization
Citations

This map shows the geographic impact of M. Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Goldman more than expected).

Fields of papers citing papers by M. Goldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Goldman. The network helps show where M. Goldman may publish in the future.

Co-authorship network of co-authors of M. Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Goldman. A scholar is included among the top collaborators of M. Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Goldman. M. Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoser, Benedikt, Drago Bratkovic, Barry J. Byrne, et al.. (2021). POMPE DISEASE. Neuromuscular Disorders. 31. S108–S109. 1 indexed citations
2.
Li, Yan, et al.. (2018). Longitudinal Modeling of Prebronchodilator FEV1 Response to Benralizumab for Patients with Severe Asthma. Pneumologie. 72(S 01). S14–S15. 1 indexed citations
3.
Chia, Yen Lin, et al.. (2018). Relationship between Benralizumab Exposure and Asthma Exacerbation Rate for Patients with Severe Asthma. Pneumologie. 72(S 01). S15–S15. 1 indexed citations
4.
Shah, Shailen, William W. Busse, Jennifer McElhattan, Christopher D. O’Brien, & M. Goldman. (2009). Efficacy and Tolerability of Fixed-Dose (FD) and Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) and FD Fluticasone Propionate/Salmeterol Dry Powder Inhaler (FP/SAL DPI) Within Racial Groups. Journal of Allergy and Clinical Immunology. 123(2). S80–S80. 4 indexed citations
5.
6.
7.
8.
9.
10.
Bleecker, Eugene R., Dirkje S. Postma, Rachael Lawrance, et al.. (2007). Effect of Polymorphisms in the Beta2-Adrenergic Receptor Gene (ADRB2) on Response to Long-Acting Beta2-Agonist (LABA) Therapy. Journal of Allergy and Clinical Immunology. 119(2). 524–525. 9 indexed citations
11.
Goldman, M., et al.. (2005). COUNSEL OF RECORD. 1 indexed citations
12.
Goldman, M., Robert Zackin, Carl J. Fichtenbaum, et al.. (2004). Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy. Clinical Infectious Diseases. 38(10). 1485–1489. 87 indexed citations
13.
Smedema, Melinda, et al.. (2003). Relapse of coccidioidomycosis despite immune reconstitution after fluconazole secondary prophylaxis in a patient with AIDS. Mycoses. 46(1-2). 42–44. 13 indexed citations
14.
Hiller, F. Charles, Vivian Alderfer, & M. Goldman. (2003). Long-term use of Viozan™ (sibenadet HCl) in patients with chronic obstructive pulmonary disease: results of a 1-year study. Respiratory Medicine. 97. S45–S52. 7 indexed citations
15.
Goldman, M., et al.. (2002). Mucosal and invasive fungal infections in HIV/AIDS.. PubMed. 7(5). 236–41. 22 indexed citations
16.
Goldman, M., Melinda Smedema, Patricia Connolly, et al.. (2001). DNA fingerprinting of serialCandida albicansisolates obtained during itraconazole prophylaxis in patients with AIDS. Medical Mycology. 39(2). 207–213. 3 indexed citations
17.
White, Mary H., Raleigh A. Bowden, Eric Sandler, et al.. (1998). Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia. Clinical Infectious Diseases. 27(2). 296–302. 212 indexed citations
18.
Goldman, M. & John C. Pottage. (1995). Cryptococcal Infection of the Breast. Clinical Infectious Diseases. 21(5). 1166–1169. 7 indexed citations
19.
Goldman, M., et al.. (1981). [Parathyroid adenoma detected by a cold nodule on thyroid scintigraphy with technetium].. PubMed. 10(4). 254–5. 1 indexed citations
20.
Dattwyler, Raymond J., M. Goldman, & Kenneth D. Bloch. (1979). Pneumomediastinum as a complication of asthma in teenage and young adult patients. Journal of Allergy and Clinical Immunology. 63(6). 412–416. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislas Nimubona Breakdown of academic impact, for papers by D Mattson Breakdown of academic impact, for papers by AO Soubani Breakdown of academic impact, for papers by T. Schmeiser Breakdown of academic impact, for papers by Naoki Hosogaya Breakdown of academic impact, for papers by Fumiyuki Kuze Breakdown of academic impact, for papers by Inge Muylle Breakdown of academic impact, for papers by J Muszyński Breakdown of academic impact, for papers by Joseph J. Nania Breakdown of academic impact, for papers by Hideki Ikeda
Rankless by CCL
2026